12 results
La HAS, en accord avec sa commission technique des vaccinations, considère primordial le maintien de l’ensemble des vaccinations obligatoires des nourrissons (à 2, 4, 5, 11, 12 et 16-18 mois)...
Home-based record (HBR) for France circa 2014 (adolescent-adult)
During 2003–2009, substantial progress was made toward the previous goal of measles elimination in the World Health Organization (WHO) European Region (EUR) by 2010 (1,2). However, since late 2009,...
The internet is playing an increasingly important part in fueling vaccine related controversies and in generating vaccine hesitant behaviors. English language Antivaccination websites have been...
Disease-specific adverse events following nonlive vaccines: A paradoxical placebo effect or a nocebo
Vaccines can cause adverse reactions (AR), i.e. adverse events following immunization (AEFIs) due to the vaccine, such as local reactions or fever. In addition, live attenuated vaccines which...
Vaccination with the 7-valent pneumococcal conjugate vaccine (PCV7) was recommended in France in 2003 for children <2 years. The 13-valent conjugate vaccine (PCV13) replaced PCV7 in 2010. The...
In France, recent developments in healthcare system organization have aimed at strengthening decision-making and action in public health at the regional level. Firstly, the 2004 Public Health Act, by...
The first human vaccination with a rabies virus attenuated by exposure to dry air started on July 6, 1885, and was reported in the session of the French Academy of Sciences on October 26, 1885 (1)....
Whooping cough is a relatively new infectious disease afflicting human beings, compared with other infectious diseases, and is undergoing a resurgence despite decades of vaccination. The oldest known...
OBJECTIVES: In recent years, vaccine hesitancy among health professionals has emerged as an important issue on public health agendas. However, we do not yet know very much about whether, and if so...